Le Lézard
Classified in: Health
Subjects: NPT, WOM, DEI

THE HOWARD AND GEORGEANNA JONES FOUNDATION FOR REPRODUCTIVE MEDICINE ANNOUNCES A $5,000 PRIZE OPPORTUNITY


VIRGINIA BEACH, Va., Nov. 10, 2022 /PRNewswire/ -- The Howard and Georgeanna Jones Foundation for Reproductive Medicine in partnership with The O'Neill Institute for National and Global Health Law at Georgetown University Law Center, is pleased to announce the Post-Dobbs Assisted Reproductive Technologies and the Law Writing Competition to encourage original writing on the impacts of the Dobbs decision on assisted reproductive technologies ("ART").

The Jones Foundation promotes the singular, historical vision and impact of IVF pioneers, Drs. Howard and Georgeanna Jones, and as part of its mission to advance scientific and medical research in the field of reproductive medicine, strives to educate the general public, scientific leaders, legislators, and public policy leaders to help make informed decisions regarding fertility treatment and reproductive medicine.

Entrants are invited to submit papers exploring how the June 2022 U.S. Supreme Court decision in Dobbs v. Jackson Women's Health Organization may affect access to assisted reproductive technologies and considering what comes next. Preference will be given to papers that present an original perspective, provide analysis and insights, examine emerging questions, or that propose novel legal structures to engage with the impacts this decision may have on access to the ARTs.

For more information on competition rules, the deadline and submission of papers please visit the Jones Foundation website, www.jonesfound.org

"With the potential impacts of the U.S. Supreme Court's decision in Dobbs on ART providers and patients rapidly unfolding in real-time, this competition is intended to provide an opportunity to explore these critical issues, raise public awareness of, and provide guidance on, future directions for the assisted reproductive technologies and those who provide and utilize them. said Robert W. Jones, Chairman of the Board. "We are especially pleased to present this opportunity in partnership with Georgetown University Law Center's O'Neill Institute for National and Global Heath Law," said Mr. Jones.

About The Howard and Georgeanna Jones Foundation for Reproductive Medicine

The Howard and Georgeanna Jones Foundation for Reproductive Medicine is a 501(c)(3) organization that solicits funds from the general public to support scientific and medical research and education in the field of reproductive medicine. In addition to providing research grants to deserving scientific investigators, the Foundation Board of Directors is prepared to serve in an advisory capacity to the agencies it supports. The Foundation may also sponsor seminars or other educational activities designed to evaluate public policy issues related to reproductive medicine in order to educate the general public and attempt to improve the human condition.

SOURCE The Howard and Georgeanna Jones Foundation for Reproductive Medicine


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: